Medical Termination of Pregnancy : Evaluation of Patients' Practices and Feelings in Brest Hospital

NCT ID: NCT04294212

Last Updated: 2020-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-10

Study Completion Date

2020-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluate the feelings of patients about a medical termination of pregnancy that they experienced in Brest Hospital. Patients responded to an online questionnaire assessing their feelings at each stage of the medical termination process. Their answers were associated with their medical data.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medical Termination of Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient having experienced a medical termination of pregnancy in Brest Hospital
* Medical termination of pregnancy after 14 weeks
* Induction for natural delivery
* No opposition

Exclusion Criteria

* Medical termination of pregnancy before 14 weeks
* Selective termination of pregnancy (multiple pregnancy)
* Caesarean
* Patient not speaking french
* Patient's refusal
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Brest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHRU de Brest

Brest, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anne-Hélène Saliou

Role: CONTACT

02-98-22-35-33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anne-Hélène saliou

Role: primary

02-98-22-35-33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IMGEPR (29BRC19.0245)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Misoprostol for Non-Viable Pregnancies
NCT00426491 COMPLETED PHASE3